The EPS projection of Amedisys Inc (NASDAQ:AMED) for quarter ended 2016-09-30 is $0.47. Last week, the EPS forecast was $0.47 against target of $0.47, a month earlier. Two months ago, this estimate was $0.47 versus forecast of $0.47 three months earlier, implying a deviation of 0%.
Amedisys Inc (NASDAQ:AMED) stated that 18 days ago, its stock price was positively revised 3 times while negative revisions were 1.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 3, 1, and 1, correspondingly.
EPS estimate downgrade for Amedisys Inc (NASDAQ:AMED) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
Amedisys Inc (NASDAQ:AMED) EPS target for the quarter closed 1 was $0.47, based on 6 recommendations. As reported on 2016-05-03 the EPS was $0.33. The change was $-0.01, implying a percentage deviation of -2.94%. The projections showed a standard deviation of 0.01.
Quarterly Sales Estimates
Amedisys Inc (NASDAQ:AMED) yearly sales prediction for the fiscal 2017 stands at $383.706 and the median estimate is at $383.973. Almost 4 analysts issued sales target.
Highest sales target is $388.58 while the lowest target is $378.3 showing standard deviation of 4.307%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Amedisys Inc (NASDAQ:AMED) announced that the deviation in forecast was 0.488%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...